Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 37,025 | 19,658 | 20,219 | -97,073 | 94,284 |
| Depreciation Amortization | 15,784 | 17,161 | 18,516 | 20,867 | 22,605 |
| Income taxes - deferred | -10,811 | 433 | 6,012 | -12,216 | -36,345 |
| Accounts receivable | -2,618 | -10,078 | -13,522 | 46,421 | -3,191 |
| Accounts payable and accrued liabilities | -12,878 | 15,374 | 6,568 | -12,838 | -3,757 |
| Other Working Capital | -28,772 | -25,019 | -20,563 | 5,939 | -7,707 |
| Other Operating Activity | 27,059 | 7,427 | 19,349 | 106,768 | 23,638 |
| Operating Cash Flow | $24,789 | $24,956 | $36,579 | $57,868 | $89,527 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,094 | -8,327 | -12,861 | -10,146 | -21,382 |
| Net Acquisitions | N/A | 240 | 873 | -225 | 2,980 |
| Purchase Sale Intangibles | 67 | -29 | -318 | -498 | -180 |
| Other Investing Activity | 3,442 | 4,231 | 1,765 | 18,222 | 12,725 |
| Investing Cash Flow | $-6,652 | $-3,856 | $-10,223 | $7,851 | $-5,677 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 202,000 | 116,000 | 155,000 | 56,000 | 138,000 |
| Debt Repayment | -211,000 | -131,000 | -226,000 | -102,000 | -123,000 |
| Common Stock Issued | N/A | N/A | 60,000 | N/A | N/A |
| Common Stock Repurchased | -2,202 | -3,903 | -8,256 | -2,793 | -3,308 |
| Dividend Paid | -1,868 | -1,853 | -1,834 | -12,446 | -97,574 |
| Other Financing Activity | -5,375 | -2,619 | -1,369 | -1,766 | 8 |
| Financing Cash Flow | $-18,445 | $-23,375 | $-22,459 | $-63,005 | $-85,874 |
| Beginning Cash Position | 15,428 | 17,703 | 13,806 | 11,092 | 13,116 |
| End Cash Position | 15,120 | 15,428 | 17,703 | 13,806 | 11,092 |
| Net Cash Flow | $-308 | $-2,275 | $3,897 | $2,714 | $-2,024 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,789 | 24,956 | 36,579 | 57,868 | 89,527 |
| Capital Expenditure | -10,579 | -10,216 | -13,539 | -11,880 | -22,269 |
| Free Cash Flow | 14,210 | 14,740 | 23,040 | 45,988 | 67,258 |